Caricamento...
SUN-319 Failure Of Pasireotide To Control Hypoglycemia In A Men-1 Patient With Metastatic Insulinoma
Background: Pasireotide appears to be a promising therapeutic approach to refractory hyperinsulinemic hypoglycemia, since hyperglycemia is a frequent side effect when used in the treatment of other neuroendocrine diseases. Clinical case: A 39-year-old woman with MEN1 and severe hypoglycemic episodes...
Salvato in:
| Pubblicato in: | J Endocr Soc |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Endocrine Society
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553365/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-319 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|